Drs. Karl and Spencer discuss BS supplements claiming to be like Ozempic along with discuss some new obesity drugs coming down the pipeline that were announced in phase 1 and 2 trials.Are there any supplements that can mimic Ozempic?What is amylin and how does it help with weight and sugars?What is this new oral drug "amycretin" in phase 1 trials?and more

Dr. Jen Gunter, a renowned expert on women's health, dives deep into the often misunderstood world of menopause. She debunks myths and highlights the significance of personalized care. The discussion covers hormonal vs. non-hormonal treatment options, emphasis on holistic health, and the risks associated with bioidentical hormones. Gunter stresses the critical need for informed decision-making, navigating societal pressures, and understanding individual health factors, all while blending humor with insightful expertise.

Dr. Karl, an expert in the use of liraglutide for Alzheimer's, and Dr. Spencer, a researcher analyzing heart failure treatments, explore enticing breakthroughs in GLP-1 medications. They delve into promising results from trials that indicate potential benefits for Alzheimer's and heart failure patients. The conversation shifts to the controversial intersection of sports and health metrics, critiquing BMI for athletes and discussing the women's boxing controversy, highlighting the need for more nuanced health assessments in sports.

Dr. Rachel Pessah-Pollack, a distinguished bone expert endocrinologist, joins the discussion on the latest Vitamin D guidelines. They delve into whether healthy individuals should check their vitamin D levels and the specifics of supplementation. The conversation highlights the shift from blanket recommendations to targeted strategies for at-risk groups. Key insights on the complexities of Vitamin D measurement and monitoring parathyroid hormone levels for managing osteoporosis are also explored, providing valuable knowledge on safe supplementation practices.

Explore the potential link between semaglutide and blindness, including the risks of NAION and worsening diabetic retinopathy. Learn about the study analyzing patient outcomes and the concerns surrounding bias in research. Find out how to minimize the risk of vision issues through lifestyle changes and monitoring eye health.

Tirzepatide may be a good option if you have obesity and obstructive sleep apnea.Click here to read the study

Discover the groundbreaking study on a new obesity treatment targeting hunger reduction. Learn about the innovative stomach ablation technique using high pressure saline and heat for weight loss. Explore the potential applications of stomach ablation as a transitional treatment and the FDA approval of a device for weight loss.

Drs. Karl and Spencer discuss the FLOW trial showing kidney protection with semaglutide, rant about costly medicines, compounding considerations, and the need for heart and kidney health focus in diabetes management.

Exploring the intersection of obesity medication, healthcare system dysfunctions, and societal perceptions. Delving into the impact of Hollywood's influence on vanity weight loss and the importance of prioritizing health over societal norms. Discussion on South Park's evolution in addressing societal issues through vulgarity and medication portrayal. Delve into the speaker's plans for a compounding pharmacy and potential solutions to shortages in the field.

Drs. Karl and Spencer critique the fallacies of functional medicine, highlighting concerns about excessive testing and financial motives. They explore the limitations of identifying root causes, unethical practices, and the role of regression to the mean. The discussion delves into health improvements through lifestyle factors and frustrations with the healthcare system.